JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakazawa, T.
Right arrow Articles by Yamatsu, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakazawa, T.
Right arrow Articles by Yamatsu, K.

Spinal kappa receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice

T Nakazawa, Y Furuya, T Kaneko and K Yamatsu

Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan.

E-2078 ([N-methyl-Tyr1, N-methyl-Arg7, D-Leu8]dynorphin A (1-8) ethylamide) is a systematically active dynorphin analog. We examined the sites of action of analgesia induced by systemic application of E- 2078 compared with morphine in mice. When administered either intracerebroventricularly or intrathecally, E-2078 produced maximal dose-dependent analgesia in the tail-pinch, tail-flick and formalin tests. Its peak effect was observed 15 min after both injections, contrasted with a slow peak (120 min) by subcutaneous injection. The intrathecal site was relatively more sensitive than the intracerebroventricular site and many times more sensitive than the subcutaneous route. In contrast, morphine was equipotent when given intracerebroventricularly and intrathecally. When E-2078 was administered subcutaneously and naloxone or nor-binaltorphine were given either intracerebroventricularly or intrathecally, the analgesic action of E-2078 was most potently and totally reversed by intrathecal injection of nor-binaltorphimine. Intracerebroventricular and intrathecal injections of naloxone were equally effective for antagonism of morphine-analgesia. These data indicate that systemically administered E-2078 produces analgesia via central actions, in which the activation of the spinal kappa receptors is most important.

Volume 256, Issue 1, pp. 76-81, 01/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Neurosci.Home page
M. Xu, M. R. Bruchas, D. L. Ippolito, L. Gendron, and C. Chavkin
Sciatic Nerve Ligation-Induced Proliferation of Spinal Cord Astrocytes Is Mediated by {kappa} Opioid Activation of p38 Mitogen-Activated Protein Kinase
J. Neurosci., March 7, 2007; 27(10): 2570 - 2581.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Xu, M. Petraschka, J. P. McLaughlin, R. E. Westenbroek, M. G. Caron, R. J. Lefkowitz, T. A. Czyzyk, J. E. Pintar, G. W. Terman, and C. Chavkin
Neuropathic Pain Activates the Endogenous {kappa} Opioid System in Mouse Spinal Cord and Induces Opioid Receptor Tolerance
J. Neurosci., May 12, 2004; 24(19): 4576 - 4584.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
G. Pugh Jr., D. J. Mason Jr., V. Combs, and S. P. Welch
Involvement of Dynorphin B in the Antinociceptive Effects of the Cannabinoid CP55,940 in the Spinal Cord
J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 730 - 737.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1991 by the American Society for Pharmacology and Experimental Therapeutics.